David Crockett

David K. Crockett, Ph.D. is the Senior Director of Research and Predictive Analytics. He brings nearly 20 years of translational research experience in pathology, laboratory and clinical diagnostics. His recent work includes patents in computer prediction models for phenotype effect of uncertain gene variants. Dr. Crockett has published more than 50 peer-reviewed journal articles in areas such as bioinformatics, biomarker discovery, immunology, molecular oncology, genomics and proteomics. He holds a BA in molecular biology from Brigham Young University, and a Ph.D. in biomedical informatics from the University of Utah, recognized as one of the top training programs for informatics in the world. Dr. Crockett builds on Health Catalyst’s ability to predict patient health outcomes and enable the next level of prescriptive analytics – the science of determining the most effective interventions to maintain health.

See content from David Crockett

The Real Opportunity of Precision Medicine and How to Not Miss Out

Precision medicine, defined as a new model of patient-powered research that will give clinicians the ability to select the best treatment for an individual patient, holds the key that will allow health IT to merge advances in genomics research with new methods for managing and analyzing large data sets.
This will accelerate research and biomedical discoveries. However, clinical improvements are often designed to reduce variation. So, how do systems balance tailoring medicine to each patient with standardizing care?
The answer is precise registries. For example, using registries that can account for the most accurate, specific patients and disease, clinicians can use gene variant knowledge bases to provide personalized care.

This site uses cookies

We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see our privacy policy for details and any questions.